Back

Risk factors of atrial arrhythmia recurrence and impact on the benefit of oral anticoagulation discontinuation: insights from the ALONE-AF trial

29 August 2026 (09:27 - 09:45)
Organised by: Logo
Congress Presentation Part of: Ablation for atrial fibrillation: new insights, better outcomes Rhythm Control, Catheter Ablation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kang Dongseon

Hallym University Sacred Heart Hospital, Anyang-Si- Gyeonggi-Do (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on ablation for atrial fibrillation: new insights, better outcomes
Professor J. Kalman (Melbourne, AU)
Slides Video
Presentation thumbnail
Long-term clinical outcomes of catheter ablation versus pacemaker implantation in patients with atrial fibrillation and sick sinus syndrome: a multicenter real-world cohort study
Mx X. Yang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
The effect of pulsed field versus radiofrequency pulmonary vein isolation on the cardiac autonomic nervous system in the BEAT PAROX-AF randomized trial
Professor D. Wichterle (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
GLP-1 receptor agonist use and clinical outcomes after atrial fibrillation ablation: a 110-center real-world analysis
Doctor N. Paisarntanawat (TH)
Abstract Slides Video

Access the full session

Session thumbnail
Ablation for atrial fibrillation: new insights, better outcomes
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 09:27 CET
You may be interested in
thumbnail
Congress Presentation
Can we stop anticoagulation following 'successful' atrial fibrillation ablation?
13 April 2026
thumbnail
Congress Presentation
Left atrial size-based anticoagulation discontinuation after catheter ablation for atrial fibrillation: a post-hoc analysis of the ALONE-AF Trial
14 April 2026
thumbnail
Congress Presentation
CHA2DS2-VASc score-based anticoagulation management after catheter ablation for atrial fibrillation: a post-hoc analysis of the ALONE-AF trial
13 April 2026
thumbnail
Congress Presentation
ALONE-AF: Discontinuing long-Term oral anticoagulation after successful atrial fibrillation ablation
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources